Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
SURF-201 · 1 trial · 2 indications
The Investigator used a slit lamp biomicroscope to assess ACCs in the study (surgery) eye. ACC counts were graded as follows: ACC Grade 0 = 0 cells were seen ACC Grade higher than 0 = 1 or more cells were seen
| Arm | Type | Description |
|---|---|---|
| SURF-201 | EXPERIMENTAL | 0.2% topical preservative-free corticosteroid solution (0.2% betamethasone sodium phosphate) |
| Vehicle | PLACEBO_COMPARATOR | Topical preservative-free vehicle (Placebo) |
| Name | Type | Description |
|---|---|---|
| SURF-201 | DRUG | One drop twice daily (BID) in the study eye for 16 days. |
| Placebo | DRUG | One drop twice daily (BID) in the study eye for 16 days. |
Inclusion Criteria: 1. Adult subjects age 18 years or older scheduled for uncomplicated unilateral cataract surgery with posterior chamber intraocular lens (IOL) implantation. 2. Subjects must be able to understand and sign the Informed Consent Form (ICF). 3. Female subjects of childbearing potenti...
SURF-201 is an investigational small molecule eye drop being studied for the treatment of post-surgical ocular inflammation and post-surgical ocular pain following cataract surgery. It is in Phase 2 clinical development for these indications.
SURF-201 is a small molecule developed for use in ophthalmology. Its specific molecular target has not been disclosed in the available clinical trial information.
SURF-201 is being developed by Harrow, Inc., a company traded on the NASDAQ under the ticker symbol HROW.
SURF-201 is in Phase 2 clinical development. It is an investigational drug and has not been approved by the FDA for any use.
SURF-201 has been studied in one completed Phase 2 clinical trial, identified as NCT04324359. This randomized, double-blind, placebo-controlled study enrolled 91 participants in the United States to evaluate the drug's efficacy and side effects in cataract surgery subjects.
No alternative names for SURF-201 have been reported in the available clinical trial information. It is identified solely by the name SURF-201.